Viewing Study NCT05061420


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2026-01-29 @ 12:35 AM
Study NCT ID: NCT05061420
Status: TERMINATED
Last Update Posted: 2025-09-22
First Post: 2021-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ACT16903
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View